Pre-market Hot Trades in US Stocks

United Microelectronics fell 7.57% in pre-market trading. Based on recent key news:

1. On June 25, Qualcomm announced a multi-year partnership with Meta, with United Microelectronics becoming a partner in Qualcomm's ecosystem, expected to benefit operations. Qualcomm launched products like the Dragonfly C1000 CPU, driving the AI data center market, which impacted United Microelectronics' stock price negatively. Source: Zhitong Finance

2. On June 24, Taiwan's stock market plunged over a thousand points, with United Microelectronics hitting a historical high during trading, rising over 2%. The market's increased demand for mature processes benefited United Microelectronics as TSMC focused resources on advanced processes. Source: Wall Street Insight

3. On June 23, United Microelectronics released financial data, reporting a 17.8% year-on-year revenue growth in May and a 203% increase in net profit. The financial performance was strong, but the stock price was still affected by overall market volatility. Source: Jinshi Data AI demand drives growth in the semiconductor industry, with significant capital inflows.

ENDRA rose 6.74% in pre-market trading. Based on recent key news:

1. On June 25, ASP Isotopes announced a merger with ENDRA Life Sciences and plans to conduct approximately $50 million in private financing. After the merger, the company will operate under the name Noble Africa and apply for trading on NASDAQ. This news boosted ENDRA's stock price.

2. On June 25, ENDRA Life Sciences shareholders are expected to hold 3% of the merged company after the merger, while ASP Isotopes will hold approximately 89% of the shares. This adjustment in shareholding structure has attracted market attention, affecting stock prices.

3. On June 25, ASP Isotopes' CEO Paul Mann and COO Nick Mitchell will lead the merged company. The stability of the leadership has enhanced investor confidence, further driving up the stock price. The market has a positive attitude towards the merger transaction, focusing on capital flows.

Top Gainers in Pre-market US Stocks

Triller rose 95.74% in pre-market trading. Based on recent key news:

1. On June 26, Triller announced it had signed an agreement to gain economic exposure to SpaceX as a strategic asset. This move caused Triller's stock price to rise 96% in pre-market trading. Source: MT Newswires

2. On June 25, Triller announced the acquisition of a Bahamian entity holding shares in SpaceX, with a transaction amount of approximately $411.3 million, expected to be completed by July 22. This news drove the stock price up over 412% during trading. Source: Zhitong Finance

3. On June 26, Triller's CEO stated that SpaceX is one of the most outstanding companies of this generation, and Triller has gained meaningful exposure on its balance sheet. This news triggered heavy trading of Triller's stock, with trading volume far exceeding the three-month average. Source: Benzinga The market signals for Triller's technology indicate a sell Sadot pre-market up 64.72%. Based on recent news,

4. On June 24, Sadot Group executed a 1-for-20 reverse stock split. This move aimed to increase the stock price and improve market liquidity, resulting in a significant rise in the stock price.

5. On June 23, the friction issues in the agricultural supply chain faced by Sadot Group were resolved, leading to an optimistic market outlook on its future performance, which pushed the stock price up.

6. On June 22, analysts upgraded their ratings on Sadot Group, believing that improvements in supply chain management would lead to higher profitability, further stimulating the rise in stock price. The supply chain management industry has performed strongly recently, with noticeable capital inflows.

INVO Fertility pre-market up 63.71%. Based on recent key news:

1. On June 25, INVO Fertility released important documents through the EDGAR system, indicating that the company is expanding its network of fertility clinics, driving the stock price up. The document emphasized the company's strategy in integrating cooperative operation centers, which stimulated optimistic market expectations for its future growth.

2. On June 23, analysts set a 12-month target price of $20 for INVO Fertility, approximately 92.5% higher than its recent closing price. This positive analyst expectation boosted investor confidence, significantly driving up the stock price.

3. On June 22, INVO Fertility's quarterly financial report showed poor performance; however, market confidence in its long-term strategy remained strong, leading to short-term fluctuations in the stock price. The fertility health industry has performed strongly recently, with noticeable capital inflows